Related Experiment Videos
Acute encephalopathy attributed to 5-FU
C J Langer1, A Hageboutros, D D Kloth
1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Pharmacotherapy
|March 1, 1996
Abstract:
Acute encephalopathy attributable to 5-fluorouracil (5-FU) is rare. A patient experienced this reaction associated with a continuous 5-FU infusion. The etiology of the event remains uncertain, but it is generally reversible and does not preclude retreatment with 5-FU at reduced dosages. Steroids and thiamine may expedite neurologic recovery.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
Parenting and Child Correlates of Maternal Burnout.
The Journal of genetic psychology·2026
Effects of Maternal Flecainide Use in the Nursed Infant-A Case Report.
Journal of human lactation : official journal of International Lactation Consultant Association·2026